Colorectal peritoneal metastases: still a nihilistic outlook?
Vignesh Narasimhan1,2, Toan Pham1,2, Robert Ramsay1,2
1Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
ANZ Journal of Surgery
|September 16, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
8.3K
Here, we present an ablate-and-resect prospective study to evaluate the feasibility, safety, and accuracy of intraoperative high-intensity focused ultrasound ablation in patients undergoing hepatectomy for liver...
8.3K
06:01A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
9.9K
A protocol for the establishment of a genetically engineered mouse model of colorectal cancer by segmental adeno-cre infection and its surveillance via high-resolution colonoscopy is...
9.9K
08:43Orthotopic Mouse Model of Colorectal Cancer
47.0K
Two techniques can be used to establish this model: injection of a cancer cell suspension into the cecal wall or transplantation of a piece of subcutaneous tumor onto the cecum. This model is useful for studying the natural progression of colorectal cancer and testing new therapeutic agents against colorectal...
47.0K
06:51A Preclinical Murine Model of Hepatic Metastases
30.2K
A preclinical, murine model of hepatic metastases performed via a hemispleen injection...
30.2K
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
7.0K
Portal vein injection of colorectal cancer (CRC) organoids generates stroma-rich liver metastasis. This mouse model of CRC hepatic metastasis represents a useful tool to study tumor-stroma interactions and develop novel stroma-directed therapeutics such as adeno-associated virus-mediated gene...
7.0K
09:48Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
739
Here, we describe the protocol for in vivo delivery of magnetic iron oxide nanoparticles carrying RNA oligomers to metastatic breast cancer in animal models, providing a clinically viable approach for the therapeutic silencing of oncogenic nucleic...
739


